Pharmacotherapeutic group:non-steroidal anti-inflammatory drug
Dosage form:tablets 7.5 mg or 15 mg No. 20
Composition:active substance: meloxicam - 7.5 mg or 15 mg
MELOXICAM AVEXIMA possesses an anti-inflammatory, antipyretic, analgesic action.
It is important to remember, that Meloxicam more rarely causes erosive and ulcerative gastrointestinal diseases compared to non-selective cyclo-oxygenase inhibitors.
Indications for use:
Symptomatic treatment:
rheumatoid arthritis;
osteoarthritis (arthrosis, degenerative joint diseases), including those with pain syndrome;
ankylosing spondylitis (Bechterew's disease);
other inflammatory and degenerative diseases of musculoskeletal system, such as arthropathies, dorsopathies (for example, ischias, lower back pain, humeral periarthritis, etc) accompanied by pain syndrome.
Method of administration and posology:
For oral administration during the meal, not chewing, with water or other liquid, at a daily dose of 7.5-15 mg; dosing frequency - once daily.
Maximal daily dose is 15 mg; for adolescents aged 12-18 years - 0.25 mg/kg (it should not exceed 15 mg).
In patients with severe renal insufficiency on hemodialysis - 7.5 mg.
In mild to moderate renal impairment (creatinine clearance of more than 30 mL/min) and in liver cirrhosis in case of patient's stable clinical condition, no dose adjustment is required.
Starting dose for patients with increased risk of side effects is 7.5 mg/day.
Combination therapy: the medicinal product should not be used concomitantly with other NSAIDs.
Shelf life:
3 years. Do not use after the expiry date indicated on the packaging.
Manufacturer
OJSC "Irbitsky Chemical-Pharmaceutical Plant"
THERE ARE CONTRAINDICATIONS. READ THE INSTRUCTION OR CONSULT A MEDICAL SPECIALIST BEFORE USE
